Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.

MLA

Najar, Mehdi, et al. “Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.” Frontiers in Cell and Developmental Biology, vol. 9, Jan. 2022, p. 716853. EBSCOhost, https://doi.org/10.3389/fcell.2021.716853.

APA

Najar, M., Melki, R., Khalife, F., Lagneaux, L., Bouhtit, F., Moussa Agha, D., Fahmi, H., Lewalle, P., Fayyad-Kazan, M., & Merimi, M. (2022). Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization. Frontiers in Cell and Developmental Biology, 9, 716853. https://doi.org/10.3389/fcell.2021.716853

Chicago

Najar, Mehdi, Rahma Melki, Ferial Khalife, Laurence Lagneaux, Fatima Bouhtit, Douaa Moussa Agha, Hassan Fahmi, Philippe Lewalle, Mohammad Fayyad-Kazan, and Makram Merimi. 2022. “Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.” Frontiers in Cell and Developmental Biology 9 (January): 716853. doi:10.3389/fcell.2021.716853.